JSPR
JSPR
NASDAQ · Biotechnology

Jasper Therapeutics Inc

$1.35
+0.08 (+6.30%)
As of Feb 8, 2:20 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 6.30M 6.48M 4.92M
Net Income -1,316,650 -1,573,823 -1,131,717
EPS
Profit Margin -20.9% -24.3% -23.0%
Rev Growth -2.8% +6.4% +0.2%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 5.02M 4.24M 5.06M
Total Equity 28.74M 31.24M 26.47M
D/E Ratio 0.17 0.14 0.19
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -2,363,922 -2,326,744 -1,866,701
Free Cash Flow -1,722,588 -1,580,767 -1,263,847